IPO Calendar
Lead Manager
- J P Morgan Chase (471)
- Goldman Sachs (447)
- Morgan Stanley (400)
- Bank of America Merrill Lynch (347)
- Citigroup (217)
- Jefferies (204)
- Credit Suisse (180)
- Barclays (142)
- Cowen and Company (140)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (68)
- Stifel (61)
- UBS Investment Bank (50)
- RBC Capital (49)
- Evercore (49)
- BMO Capital (48)
- Wells Fargo (44)
- William Blair (36)
- Raymond James (34)
More +
IPO - Pricing (50)
UBS Investment Bank
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 9 | HubSpot Inc. | Technology | 25 | 5 | JPM | MS | UBS | 165.2% | 20.4% | ||
Jul 30 | Westlake Chemic | Basic-Industries | 24 | 11 | BRCL | UBS | 102.6% | 28.3% | |||
May 22 | JD.com Inc. | Consumer-Services | 19 | 93 | BAML | UBS | 90.1% | 10% | |||
May 9 | PBF Logistics L | Energy | 23 | 13 | BRCL | UBS | 70.1% | 20.3% | |||
May 8 | Dorian LPG Ltd. | Transportation | 19 | 7 | JPM | UBS | 52.6% | -1.9% | |||
Feb 13 | Concert Pharmac | Health-Care | 14 | 6 | UBS | WLFG | 69.3% | 1.3% | |||
Feb 13 | Installed Build | Basic-Industries | 11 | 7 | DB | UBS | 51.1% | 16.4% | |||
Oct 21 | Ferrari N.V. | Capital-Goods | 52 | 17 | BAML | UBS | 130.9% | 5.8% | |||
Jun 19 | Celyad SA | Health-Care | 68.6 | 1 | PPRJ | UBS | 61.2% | -20.4% | |||
Sep 29 | Tabula Rasa Hea | Miscellaneous | 12 | 4 | MS | UBS | WLFG | 82.6% | 24% | ||
Sep 16 | FB Financial Co | Finance | 19 | 5 | JPM | KBW | UBS | 76.6% | 9.2% | ||
Jun 22 | Selecta Bioscie | Health-Care | 14 | 5 | Stifel | UBS | 21.9% | 0% | |||
Dec 5 | SiteOne Landsca | Consumer-Non-Durables | 21 | 10 | DB | GS | UBS | 64.4% | 27% | ||
Jul 4 | Aeglea BioThera | Health-Care | 10 | 5 | BMO | COWN | UBS | 28.6% | -2.3% | ||
May 25 | WideOpenWest In | Consumer-Services | 17 | 18 | UBS | CS | RBC | 47.3% | -2.9% | ||
Jun 4 | Elevate Credit | Finance | 6.5 | 12 | UBS | CS | JEFF | 29.8% | 19.4% | ||
Jun 4 | Schneider Natio | Transportation | 19 | 29 | MS | UBS | 58.2% | 0% | |||
Sep 21 | Farfetch Limite | Miscellaneous | 20 | 44 | ALLN | JPM | UBS | 57.5% | 42.3% | ||
Jun 28 | BrightView Hold | Consumer-Non-Durables | 22 | 21 | GS | JPM | UBS | 34.8% | -2.7% | ||
May 11 | HUYA Inc. | Technology | 12 | 15 | CS | GS | UBS | 77.2% | 33.8% | ||
Mar 27 | GreenTree Hospi | Consumer-Services | 14 | 10 | BAML | MS | UBS | 40.3% | -7.1% | ||
Mar 8 | BioXcel Therape | Health-Care | 11 | 59 | BRCL | BMO | UBS | 3.2% | 0.3% | ||
Jan 25 | Gates Industria | Technology | 19 | 38 | CITI | MS | UBS | 51.6% | -2.6% | ||
Jun 28 | Noodles & Compa | Consumer-Services | 18 | 5 | BAML | MS | UBS | 144.2% | 104.2% | ||
Jun 21 | Gogo Inc | Consumer-Services | 17 | 11 | JPM | MS | UBS | 77.7% | -5.9% | ||
Apr 18 | Hannon Armstron | Consumer-Services | 12.5 | 13 | BAML | UBS | WLFG | 39.2% | -8.8% | ||
Jan 18 | 19 | 23 | BRCL | UBS | 75.5% | 30.5% | |||||
Oct 26 | MPLX LP | Energy | 22 | 17 | BAML | MS | UBS | 57.8% | 23.6% | ||
Jan 27 | Verastem Inc | Health-Care | 10 | 5 | UBS | 13.6% | 10.9% | ||||
May 13 | Applied Therape | NA | 10 | 4 | CITI | COWN | UBS | 33.6% | -6% | ||
Jul 19 | Afya Limited | Consumer-Services | 19 | 13 | BAML | GS | UBS | 53.5% | 25.5% | ||
Aug 8 | InMode Ltd. | Health-Care | 14 | 5 | BRCL | UBS | CNCD | 71% | -3.1% | ||
Oct 10 | BioNTech SE | Health-Care | 15 | 10 | JPM | BAML | UBS | 28.1% | -5.1% | ||
Oct 31 | RAPT Therapeuti | Health-Care | 12 | 3 | BMO | WLFG | UBS | 8.2% | 8.3% | ||
Nov 1 | Fangdd Network | Finance | 13 | 6 | MS | CITI | UBS | 13.8% | 0% | ||
Nov 8 | ECMOHO Ltd. | Consumer-Services | 10 | 4 | UBS | 8.4% | 1% | ||||
Jun 28 | The RealReal In | NA | 20 | 15 | CS | BAML | UBS | 131.1% | 44.5% | ||
May 8 | Kingsoft Cloud | Technology | 23.8 | 17 | JPM | UBS | CS | 85% | 0% | ||
Jul 30 | Li Auto Inc. | Consumer-Durables | 11.5 | 95 | GS | MS | UBS | 20.6% | 39.1% | ||
Sep 17 | American Well C | Health-Care | 18 | 41 | MS | GS | UBS | 66.5% | 28.2% | ||
Jan 29 | Trinity Capital | Finance | 14 | 7 | KBW | WLFG | UBS | 19.1% | 7.1% | ||
Jan 29 | Home Point Capi | Finance | 13 | 7 | UBS | CS | JPM | 85.6% | -12.9% | ||
Feb 10 | Viant Technolog | Technology | 25 | 10 | BAML | UBS | 17.7% | 128% | |||
Mar 9 | SVF Investment | Finance | 10 | 28 | CITI | UBS | DB | 19.5% | 3.3% | ||
Apr 23 | Agiliti Inc. | Health-Care | 14 | 26 | CITI | JEFF | UBS | 32.9% | 17.1% | ||
Jun 11 | Kanzhun Ltd. | Technology | 19 | 48 | GS | MS | UBS | 34.8% | 95.8% | ||
Jun 30 | Xometry Inc. | Miscellaneous | 44 | 6 | GS | JPM | UBS | 67.1% | 98.6% | ||
Oct 22 | Minerva Surgica | Health-Care | 12 | 6 | JPM | PS | UBS | 56.8% | -25% | ||
Nov 19 | Crescera Capita | Finance | 10 | 17 | UBS | 103.5% | 0.3% | ||||
Apr 18 | Centuri Holding | Public Utilities | 21 | 12 | UBS | BAML | JPM | 14.1% | 14% |
*
Lead manager or one of top three managers in an underwriting team.